Evidence map›Paper›PMID 42605439›Full record

ArticleJournal of health economics and outcomes research2026

Impact of Acute Kidney Injury on Hospitalization Outcomes in Patients with Chronic Kidney Disease Undergoing Cardiac Procedures with Cardiopulmonary Bypass in the United States.

Nicolas Pope, Abby Greenblatt, Thainá Jehá, Juliana Meyers, Christine M Solinsky, Rakesh C Arora, Yan Wang

Abstract read
In one paragraph

Article in Journal of health economics and outcomes research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nicolas PopeMedical University of South Carolina, Charleston, South Carolina.
Abby GreenblattReal World Data & Analytics, RTI Health Solutions, Research Triangle Park, North Carolina.
Thainá JeháAlexion, AstraZeneca Rare Disease, Boston, Massachusetts.
Juliana MeyersReal World Data & Analytics, RTI Health Solutions, Research Triangle Park, North Carolina.
Christine M SolinskyAlexion, AstraZeneca Rare Disease, Boston, Massachusetts.
Rakesh C AroraHarrington Heart & Vascular Institute, University Hospitals, Cleveland, Ohio.
Yan WangAlexion, AstraZeneca Rare Disease, Boston, Massachusetts.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acute kidney injury (AKI) is a common complication after cardiac surgery and is associated with more infections, prolonged recovery, longer hospital stays, increased readmission rates, greater costs, and higher mortality. Patients with pre-existing chronic kidney disease (CKD) are at particularly high risk, with this risk increasing as renal function worsens. Damage caused by AKI may be irreversible, despite a return to baseline GFR, compounding stress on remaining nephrons. Understanding risk in these populations may ultimately help to improve prevention and outcomes. Objective: Evaluate the impact of AKI on outcomes and healthcare costs among adults with CKD undergoing cardiac surgery with cardiopulmonary bypass (CPB). Methods: Multi-institutional, retrospective, observational study using the Healthcare Cost and Utilization Project Nationwide Readmissions Database, 2016-2020 datasets. The total adult cardiac surgery population were those with CKD who underwent cardiac surgery requiring CPB (reporting incidence); from which a subpopulation of adults with severe CKD (stage 3 or 4; based on ICD-10-CM codes during index hospitalization) was assessed (impact of AKI). Patients were categorized as follows, based on AKI status during index hospitalization: no AKI, AKI, or AKI requiring dialysis (a subpopulation of AKI). Results: AKI incidence during initial hospitalization was 55.9% and 77.3% in patients with CKD stage 3 and 4, respectively. AKI requiring dialysis occurred in 3.4% and 14.5% of CKD 3 and 4 patients, respectively. One-third of all AKI cases and half of AKI requiring dialysis cases occurred in patients with CKD stage 3 or 4. In patients with CKD stage 3 or 4, multivariate analysis showed AKI was associated with increased inpatient days, increased risk of 180-day readmission, higher hospitalization costs, and greater odds of in-hospital mortality. Patients experienced the greatest burden when AKI required dialysis. Conclusions: Incidence of AKI is higher in patients with preexisting CKD stage 3 or 4 vs 1 or 2 and those without CKD. The burden of AKI is elevated in patients with CKD undergoing cardiac surgery with CPB; targeted interventions are needed to prevent poor outcomes.

Indexed as

chronic lung allograft dysfunctioncost-effectiveness analysisdecision modelextracorporeal photopheresislung transplant

Identifiers

PMID42605439
PMCPMC13477740

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.